221 related articles for article (PubMed ID: 4827071)
21. Propofol anaesthesia in malignant hyperpyrexia susceptible swine.
Foster PS; Hopkinson KC; Denborough MA
Clin Exp Pharmacol Physiol; 1992 Mar; 19(3):183-6. PubMed ID: 1521353
[TBL] [Abstract][Full Text] [Related]
22. Malignant hyperpyrexia and sudden death.
Ranklev E; Fletcher R; Krantz P
Am J Forensic Med Pathol; 1985 Jun; 6(2):149-50. PubMed ID: 4025266
[TBL] [Abstract][Full Text] [Related]
23. Malignant hyperthermia suggestive hypermetabolic syndrome at emergence from anesthesia.
Christiaens F; Gepts E; D'Haese J; Camu F
Acta Anaesthesiol Belg; 1995; 46(2):93-7. PubMed ID: 8714856
[TBL] [Abstract][Full Text] [Related]
24. Pathology of malignant hyperpyrexia.
Br Med J; 1973 Feb; 1(5848):249. PubMed ID: 4685313
[No Abstract] [Full Text] [Related]
25. Succinylcholine and malignant hyperthermia.
Kalow W
Fed Proc; 1972; 31(4):1270-5. PubMed ID: 5038373
[No Abstract] [Full Text] [Related]
26. [Diagnosis of susceptibility to malignant hyperthermia using the in vitro contracture test].
Klein W; Spiess-Kiefer C; Küther G; Pongratz D; Lehmann-Horn F
Anaesthesist; 1987 Dec; 36(12):685-91. PubMed ID: 2830805
[TBL] [Abstract][Full Text] [Related]
27. Screening of malignant hyperthermia susceptible families by creatine phosphokinase measurement and other clinical investigations.
Britt BA; Endrenyi L; Peters PL; Kwong FH; Kadijevic L
Can Anaesth Soc J; 1976 May; 23(3):263-84. PubMed ID: 938964
[TBL] [Abstract][Full Text] [Related]
28. Malignant hyperpyrexia and the dental outpatient.
Wedley JR; Jaffe EC
Anaesthesia; 1973 Mar; 28(2):146-54. PubMed ID: 4696355
[No Abstract] [Full Text] [Related]
29. Histological, histochemical and ultramicroscopic findings in muscle biopsies from carriers of the trait for malignant hyperpyrexia.
Isaacs H; Frere G; Mitchell J
Br J Anaesth; 1973 Aug; 45(8):860-8. PubMed ID: 4753682
[No Abstract] [Full Text] [Related]
30. Malignant hyperpyrexia in Australia and New Zealand.
King JO; Denborough MA
Med J Aust; 1973 Mar; 1(11):525-8. PubMed ID: 4699727
[No Abstract] [Full Text] [Related]
31. Preanesthetic diagnosis of malignant hyperthermia.
Britt BA
Int Anesthesiol Clin; 1979; 17(4):63-96. PubMed ID: 391722
[No Abstract] [Full Text] [Related]
32. Malignant hyperpyrexia.
Denborough MA
Compr Ther; 1975 Dec; 1(8):51-6. PubMed ID: 770064
[TBL] [Abstract][Full Text] [Related]
33. Malignant hyperpyrexia occurring in a second Johannesburg family.
Isaacs H; Barlow MB
Br J Anaesth; 1973 Aug; 45(8):901-6. PubMed ID: 4753688
[No Abstract] [Full Text] [Related]
34. Letter: Myopathies and malignant hyperpyrexia.
Moulds RF; Denborough MA
Br Med J; 1974 Aug; 3(5929):520. PubMed ID: 4414306
[No Abstract] [Full Text] [Related]
35. A screening test for the malignant hyperpyrexia phenotype using suxamethonium-induced contracture of muscle treated with caffeine and its inhibition by dantrolene.
Halsall PJ; Ellis FR
Br J Anaesth; 1979 Aug; 51(8):753-6. PubMed ID: 497072
[TBL] [Abstract][Full Text] [Related]
36. Malignant hyperpyrexia. Further muscle studies in asymptomatic carriers identified by creatinine phosphokinase screening.
Isaacs H; Barlow MB
J Neurol Neurosurg Psychiatry; 1973 Apr; 36(2):228-43. PubMed ID: 4708457
[TBL] [Abstract][Full Text] [Related]
37. An in-vivo metabolic test for detecting malignant hyperthermia susceptibility in humans: a pilot study.
Schuster F; Metterlein T; Negele S; Kranke P; Muellenbach RM; Schwemmer U; Roewer N; Anetseder M
Anesth Analg; 2008 Sep; 107(3):909-14. PubMed ID: 18713904
[TBL] [Abstract][Full Text] [Related]
38. [Current data on the screening of malignant hyperthermia during anesthesia].
Krivosic-Horber R; Adnet P
Chirurgie; 1993-1994; 119(1-2):55-8. PubMed ID: 7995103
[TBL] [Abstract][Full Text] [Related]
39. Morphological and biochemical defects in muscles of human carriers of the malignant hyperthermia syndrome.
Isaacs H; Heffron JJ
Br J Anaesth; 1975 Apr; 47(4):475-81. PubMed ID: 124580
[TBL] [Abstract][Full Text] [Related]
40. 3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility.
Lacava C; Michalek-Sauberer A; Kraft B; Sgaragli G; Sipos E; Höller C; Kress HG; Fusi F; Weigl LG
Pharmacol Res; 2012 Jul; 66(1):80-7. PubMed ID: 22480578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
